RS
GMAB icon

R Squared’s Genmab GMAB Stock Holding History

R Squared’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,440
Closed -$92.7K – 766
2024
Q4 		$92.7K Buy
+4,440
New +$97.6K 0.09% 282

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

R Squared's GMAB Position: Q1 2025 in Review

R Squared sold out of Genmab (GMAB) in Q1 2025, closing a stake of 4,440 shares — an estimated $92.7K sold.

R Squared first reported a position in GMAB in Q4 2024 and held it in 1 quarter. The position peaked at $92.7K in Q4 2024. 219 funds tracked by Wall St. Rank hold GMAB as of Q1 2025.

  • R Squared reported no remaining Genmab position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 4,440 Genmab shares in Q1 2025, an estimated $92.7K.
  • R Squared first reported a position in Genmab in Q4 2024 and held it in 1 quarter.
  • R Squared's Genmab position peaked at $92.7K in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Genmab as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.